TABLE 1.
Fat ± Vitamin Ab |
Factors (P)c |
||||||
---|---|---|---|---|---|---|---|
Variable | NF− | NF+ | HF− | HF+ | F | VA | F × VA |
Final body weight (g) | 509.8 ± 64.4 | 536.1 ± 36.9 | 577.1 ± 33.1 | 593.7 ± 55.2 | <0.0001 | 0.14 | 0.82 |
Liver weight (g) | 19.3 ± 4.2 | 20.5 ± 2.8 | 22.5 ± 3.0 | 21.2 ± 2.9 | 0.047 | 0.97 | 0.19 |
Perirenal adipose (g) | 14.3 ± 5.2 | 16.8 ± 3.4 | 21.8 ± 6.1 | 23.7 ± 6.9 | <0.0001 | 0.17 | 0.83 |
Epididymal adipose (g) | 9.3 ± 2.1 | 11.9 ± 1.9 | 15.8 ± 3.0 | 15.7 ± 4.1 | <0.0001 | 0.15 | 0.12 |
Serum R (μmol/L) | 0.50 ± 0.12 | 1.41 ± 0.31 | 0.47 ± 0.12 | 1.47 ± 0.34 | 0.86 | <0.0001 | 0.58 |
Serum CRP (mg/L)d | 150.3 ± 24.8 | 114.5 ± 20.6 | 143.3 ± 57.2 | 126.8 ± 31.6 | 0.86 | 0.094 | 0.52 |
Liver fat (mg/g) | 33.3 ± 14.6 | 34.1 ± 11.0 | 44.6 ± 9.5 | 44.7 ± 10.5 | 0.002 | 0.88 | 0.93 |
MRDR ratioe | 1.23 ± 0.37 | 0.16 ± 0.05 | 1.58 ± 0.37 | 0.16 ± 0.08 | 0.21 | <0.0001 | 0.21 |
Values (n = 12 per treatment group) represent least squares means ± SD, with significant differences (P < 0.05) by variable.
Treatment groups follow: NF- 6% dietary fat, 17 nmol retinyl acetate daily; NF+ 6% dietary fat, 70 nmol retinyl acetate daily; HF- 21% dietary fat, 17 nmol retinyl acetate daily; HF+ 21% dietary fat, 70 nmol retinyl acetate daily.
Factors include the main effects of dietary fat (F) and vitamin A (VA) and the interaction between fat and vitamin A (F × VA).
Serum CRP is n = 6 per treatment group.
The modified relative dose response (MRDR) ratio is the molar concentration of 3,4-didehydroretinol to retinol (R) in the serum 4 h after dosing with 3,4-didehydroretinyl acetate (n = 4 per treatment group).